- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 10.3 EQRX 2019 Stock Option and Grant Plan
- 10.11 Eqrx, Inc. Form of Employee Confidentiality, Assignment and Non-solicitation Agreement
- 10.32 Amended and Restated Registration Rights Agreement
- 23.1 Consent of Withumsmith+brown, PC
- 23.2 Consent of Ernst & Young LLP
- 99.2 Consent of Paul Berns to Be Named As a Director
- 99.3 Consent of Alexis Borisy to Be Named As a Director
- 99.4 Consent of Jorge Conde to Be Named As a Director
- 99.5 Consent of Sandra Horning to Be Named As a Director
- 99.6 Consent of Clive Meanwell to Be Named As a Director
- 99.7 Consent of Sam Merksamer to Be Named As a Director
- 99.8 Consent of Melanie Nallicheri to Be Named As a Director
- 99.9 Consent of Krishna Yeshwant to Be Named As a Director
- 99.10 Consent of Houlihan Loukey Capital, Inc.
- Download Excel data file
- View Excel data file
- 2 Dec 21 EFFECT Notice of effectiveness
- 1 Dec 21 424B3 Prospectus supplement
- 30 Nov 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Nov 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Oct 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 1 Oct 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
25 Aug 21 S-4 Registration of securities issued in business combination transactions
- 23 Nov 21 Registration of securities issued in business combination transactions (amended)
- 29 Oct 21 Registration of securities issued in business combination transactions (amended)
- 1 Oct 21 Registration of securities issued in business combination transactions (amended)
- 25 Aug 21 Registration of securities issued in business combination transactions
Exhibit 99.9
August 25, 2021
CM LIFE SCIENCES III, INC.
c/o Corvex Management LP
667 Madison Avenue
New York, New York 10065
Consent to Reference in Proxy Statement/Prospectus
CM Life Sciences III, Inc. (the “Company”) is filing a Registration Statement on Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus included in the Registration Statement and any and all amendments and supplements thereto as a member of the board of directors of the Company following the consummation of the business combination as described in the proxy statement/prospectus.
Sincerely, | |
/s/ Krishna Yeshwant | |
Name: Krishna Yeshwant |